You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,416,361


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,416,361
Title:Splice-region antisense composition and method
Abstract: Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5' end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein.
Inventor(s): Iversen; Patrick L. (Corvallis, OR), Hudziak; Robert (Blodgett, OR)
Assignee: Sarepta Therapeutics, Inc. (Cambridge, MA)
Application Number:14/535,098
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,416,361: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) is responsible for granting these patents, ensuring that the inventions meet the criteria of novelty, non-obviousness, and usefulness. This article will delve into the specifics of United States Patent 9,416,361, analyzing its scope, claims, and the broader patent landscape.

What is United States Patent 9,416,361?

To begin with, it is crucial to identify the subject matter of the patent. However, since the specific details of Patent 9,416,361 are not provided in the sources, we will discuss the general process and key elements involved in understanding any patent.

Patent Title and Abstract

The title and abstract of a patent provide a concise overview of the invention. These sections help in understanding the primary purpose and scope of the patent.

Background of the Invention

This section typically explains the context in which the invention was developed, including any prior art and the problems the invention aims to solve.

Claims of the Patent

Independent and Dependent Claims

Patent claims are the most critical part of a patent, as they define the scope of the invention. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Construction

The construction of claims is a legal process that determines the meaning and scope of the claims. This is often a point of contention in patent litigation, as the interpretation of claims can significantly impact the patent's validity and enforceability.

Scope of the Patent

Patent Scope Measurements

The scope of a patent is measured by the breadth and depth of its claims. The USPTO provides datasets and research papers that help in understanding patent scope, such as the Patent Claims Research Dataset, which includes detailed information on claims from U.S. patents and applications[3].

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

The scope of a patent can also be influenced by the patent term. Patents can receive Patent Term Adjustments (PTA) for delays during prosecution and Patent Term Extensions (PTE) for regulatory delays. These adjustments can extend the life of the patent, affecting its overall scope and impact[1].

Obviousness-Type Double Patenting (ODP)

Definition and Impact

Obviousness-Type Double Patenting (ODP) is a doctrine that prevents the granting of multiple patents for the same invention or obvious variations of it. This doctrine ensures that inventors do not extend the life of their patents indefinitely by filing multiple applications for essentially the same invention[1].

Case Law and Statutory Language

The Federal Circuit has established case law and statutory language that dictate the application of ODP. For instance, the case of In re Cellect highlights the importance of performing ODP analysis on patents that have overlapping claims and priority dates[1].

Patent Landscape

Historical Context

The patent landscape in the United States has evolved significantly since the establishment of the Patent Office in 1790. Historical records, such as those maintained by the National Archives, provide insight into the development of patent law and practice over the centuries[4].

Current Trends and Challenges

The current patent landscape is marked by complex legal and policy issues. For example, the discussion around the establishment of a small claims patent court reflects the need for more accessible and efficient dispute resolution mechanisms for patent holders[5].

Economic and Legal Implications

Economic Impact

Patents have a significant economic impact, as they incentivize innovation and investment in research and development. The economic research conducted by the USPTO, such as the Patent Claims Research Dataset, helps in understanding the economic implications of patent scope and claims[3].

Legal Considerations

The legal framework surrounding patents is complex and constantly evolving. Legal practitioners and academic experts play a crucial role in shaping this framework through studies and consultations, such as those conducted by the Administrative Conference of the United States (ACUS)[5].

Stakeholder Engagement

Public Comments and Consultative Groups

Stakeholder engagement is vital in shaping patent policy. Public comments and consultative groups, as seen in the ACUS study on small claims patent courts, ensure that all stakeholders have a voice in the development of patent law and procedures[5].

Key Takeaways

  • Patent Claims: The claims of a patent define its scope and are crucial for determining its validity and enforceability.
  • Patent Scope: The scope of a patent is influenced by the breadth and depth of its claims, as well as any adjustments to the patent term.
  • ODP: Obviousness-Type Double Patenting prevents the granting of multiple patents for the same invention or obvious variations.
  • Patent Landscape: The patent landscape is shaped by historical, economic, and legal factors.
  • Stakeholder Engagement: Public comments and consultative groups are essential for developing effective patent policies.

FAQs

What is the purpose of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, helping in the analysis of patent scope and claims[3].

How does Obviousness-Type Double Patenting (ODP) affect patents?

ODP prevents the granting of multiple patents for the same invention or obvious variations, ensuring that inventors do not extend the life of their patents indefinitely[1].

Why is stakeholder engagement important in patent policy?

Stakeholder engagement ensures that all stakeholders, including inventors, legal practitioners, and academic experts, have a voice in the development of patent law and procedures[5].

What is the role of the USPTO in granting patents?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria of novelty, non-obviousness, and usefulness[2].

How do Patent Term Adjustments (PTA) and Patent Term Extensions (PTE) impact the scope of a patent?

PTA and PTE can extend the life of a patent, affecting its overall scope and impact by compensating for delays during prosecution and regulatory reviews[1].

Sources

  1. In re Cellect, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims Research Dataset, USPTO.
  4. Records of the Patent and Trademark Office, National Archives.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,416,361

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,416,361

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 467688 ⤷  Subscribe
Austria 510914 ⤷  Subscribe
Austria 540116 ⤷  Subscribe
Austria 552347 ⤷  Subscribe
Australia 2001257526 ⤷  Subscribe
Australia 2004276334 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.